NSV Partners III GP LLC's Form 4 filing
Ventyx Biosciences, Inc. (VTYX) · filed Jul 11, 2023
- Accession no.
- 0000950170-23-032585
- Filed
- Jul 11, 2023, 9:13 PM ET
- Trade date
- Jul 7, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market sales total $3.52M. It was filed 4 days after the trade.
This filing was later replaced by the amendment 0000950170-23-033576 (Jul 19, 2023). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| NSV Partners III GP LLCCIK 0001889601 | 10% Owner |
| NSV Partners III LPCIK 0001890004 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 7, 2023 | Common Stock | SSaleDisposed | −75,686 | $34.99F1 | −$2,648,094.2 | 9,577,279 | Direct | |
| Jul 7, 2023 | Common Stock | SSaleDisposed | −20,718 | $35.82F5 | −$742,170.56 | 9,556,561 | Direct | |
| Jul 7, 2023 | Common Stock | SSaleDisposed | −3,596 | $36.93F6 | −$132,792.01 | 9,552,965 | Direct | |
| Jul 7, 2023 | Common Stock | JOtherDisposed | −1,030,341 | $0.00 | $0 | 8,522,624 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents the weighted average share price of an aggregate total of 75,686 shares sold in the price range of $34.52 to $35.515. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Represents the weighted average share price of an aggregate total of 20,718 shares sold in the price range of $35.52 to $36.465. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
Represents the weighted average share price of an aggregate total of 3,596 shares sold in the price range of $36.525 to $37.22. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.